Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)
Clinical trial NCT01841684 · TERMINATED
Trial details
- NCT number
- NCT01841684
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-06-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.